PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,592,217 | -57.7% | 260,443 | -49.6% | 0.69% | -56.7% |
| Q1 2023 | $25,048,082 | +19167.8% | 517,095 | +14759.1% | 1.60% | +15920.0% |
| Q1 2022 | $130,000 | -97.5% | 3,480 | -97.4% | 0.01% | -96.8% |
| Q4 2021 | $5,275,000 | -38.4% | 132,448 | -42.4% | 0.31% | -39.3% |
| Q3 2021 | $8,559,000 | -65.2% | 230,019 | -60.5% | 0.51% | -64.2% |
| Q2 2021 | $24,599,000 | +11.3% | 581,940 | +24.7% | 1.42% | +6.7% |
| Q1 2021 | $22,105,000 | +14.4% | 466,840 | +47.5% | 1.33% | +15.6% |
| Q4 2020 | $19,315,000 | +2.0% | 316,478 | -21.9% | 1.15% | -18.1% |
| Q3 2020 | $18,941,000 | -14.8% | 405,152 | -7.6% | 1.40% | +0.2% |
| Q2 2020 | $22,239,000 | +70.6% | 438,270 | +50.0% | 1.40% | +16.3% |
| Q1 2020 | $13,035,000 | -47.5% | 292,217 | -43.5% | 1.21% | -32.6% |
| Q4 2019 | $24,836,000 | +155.6% | 517,092 | +80.0% | 1.79% | +103.9% |
| Q3 2019 | $9,715,000 | -41.5% | 287,245 | -22.1% | 0.88% | -42.4% |
| Q2 2019 | $16,601,000 | +251.0% | 368,903 | +163.2% | 1.52% | +405.0% |
| Q2 2018 | $4,729,000 | +579.5% | 140,183 | +444.8% | 0.30% | +151.7% |
| Q1 2018 | $696,000 | – | 25,729 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |